Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors
(Sprache: Englisch)
Type 2 diabetes mellitus is a progressive disease that affects almost 8.3% of global population. Regardless the availability of vast variety of oral hypoglycemics, only 36% of patients achieves proper glycemic control. With the advantage of low risk of...
Leider schon ausverkauft
versandkostenfrei
Buch
35.90 €
17 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors “
Klappentext zu „Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors “
Type 2 diabetes mellitus is a progressive disease that affects almost 8.3% of global population. Regardless the availability of vast variety of oral hypoglycemics, only 36% of patients achieves proper glycemic control. With the advantage of low risk of hypoglycemia, DPP-IV attracted the attention of medicinal chemists as a new target for oral hypoglycemics. In this report, a lead compound 1, with antipyrine scaffold, was obtained, and its binding mode was calculated. Several derivatives with bridged nitrogenous heterocycles have been synthesized via multi-component reaction under controlled microwave heating conditions. The antidiabetic activity vs. DPP-IV protein was evaluated and compared with sitagliptin. Compounds with small or medium sized nitrogenous bridges were comparable with sitagliptin in term of DPP-IV inhibitory activity, potentially via targeting Glu203 and Glu204. The oral hypoglycemic activities of compounds with submicromolar IC50 values were further evaluated using diabetic mouse model.
Bibliographische Angaben
- Autor: Mohamed Abdalla
- 2017, 60 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3659800295
- ISBN-13: 9783659800290
Sprache:
Englisch
Kommentar zu "Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors"
0 Gebrauchte Artikel zu „Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors".
Kommentar verfassen